Combining Intratumoral Flu Vaccine and Systemic Pembrolizumab in Patients With Early pMMR Colorectal Cancer
Clinical trial NCT05909423 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT05909423
- Sponsor
- Zealand University Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-09-01
- Primary completion
- 2025-09-01
- Enrollment
- 21
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.